Tumour
Ehrlich Lettre hyperdiploid ascites tumour was obtained from Dr. E. L. French (Melbourne) in 1965. It was carried by serial passage in adult CBA mice up to the 20th passage for the present work.
Immunizing Procedure
Ascites from CBA mice injected 7 to 10 days previously was collected in heparin and incubated with an equal volume of 0-01 M sodium iodoacetate for 1 hour at 370 C. and pH 7-4. After incubation, the mixture was diluted with physiological saline and each mouse was injected intraperitoneally with 2-5 x 106 cells in 0-5 ml. of suspending medium. The mice were boosted twice at 14-day intervals with 2-5 x 106 freshly prepared, iodoacetate-treated cells.
Three batches of mice were immunized as above for subsequent challenge. Batch I consisted of 15 CBA mice, Batch II, 40 CBA mice and Batch III, 40 Herston white mice. Additional batches of CBA mice were immunized with various E.A.T. cell preparations (sonicated and iodoacetate-treated cells-see below) for hypersensitivity testing.
Challenge
After the second booster dose all 3 batches of mice were divided into 3 groups. Each group was challenged intraperitoneally with 2-5 x 106 live, fresh E.A.T cells at varying time intervals after the third immunizing dose.
Delayed Hypersensitivity Test
The hind feet of individual mice were measured with a caliper before injection of sonicated E.A.T. cells into the soles and at varying intervals (6 hours, 24 hours, 48 hours) after injection. Sonicated cells were prepared by ultrasonic disintegration of washed E.A.T. cells (20 per cent suspension in saline). One foot was injected with the sonicated cells (0.02 ml.) and the other foot with the same volume of saline as control. The mean increases in foot thickness at different intervals after injection were calculated. Immunized and normal mice, each in groups of 8, were compared for their response to sonicated cells.
Serological Determinations
The mice were bled at regular intervals from the tail vein and serum collected and stored for serological determinations. Various tests were carried out in an attempt to demonstrate circulating antibodies in the sera taken at different stages of immunization. Normal mou. e serum and immune guinea-pig serum (from animals injected with sonicated EA.T. cells in Freund's adjuvant) were used as negative and positive controls.
(a) Double diffusion tests were performed using the micro-technique described by Wadsworth (1957), with sonicated E.A.T. cell extracts and ascitic fluid as antigen (both of these materials were used undiluted and diluted 1: 5 with saline).
(b) Phagocytosis of washed E.A.T. cells in the presence of immune sera by guinea-pig peritoneal macrophages was tested by the method of Bennett (1965) . Macrophages were cultivated for 24 hours on glass coverslips in medium 199 containing guinea-pig serum. Mixtures of E.A.T. cells, guinea-pig serum, and the serum to be tested were then added to the macrophage cultures and incubated '347 for a further 11 hours. The coverslips were rinsed in saline, fixed in methanolacetic acid-water (90: 1: 9) and stained with buffered Giemsa. The stained preparations were examined microscopically for ingestion of tumour cells by macrophages.
(c) Agglutination tests were carried out with washed E.A.T. cells (3 per cent suspension) and serial dilutions of the immune sera in Dulbecco phosphate buffer. Coombs' test was also applied using E.A.T. cells pretreated with the immune serum, with the further addition of goat anti-mouse y-globulin.
(d) Cytotoxic tests were performed with serial dilutions of the immune sera in Dulbecco phosphate buffer in the presence of washed E.A.T. cells (3 per cent suspension) and complement (1: 15 guinea-pig serum). Uptake of trypan blue (0.01 per cent) was taken as the index of cytotoxic action and cell death.
Preparation of Vy and 72 globulins
Serum from immunized CBA mice (5 ml.) was treated with two volumes of 27 per cent (w/v) sodium sulphate and maintained at 370 C. overnight. The precipitate was collected by centrifugation, dissolved in normal saline (2 ml.) and dialysed against starting phosphate buffer (0.009 M K2HPO4, 0-001 M KH2PO4, pH 7.9). This solution, containing mainly globulins, was applied to a DEAEcellulose (Whatman DE-1) column (2 x 40 cm.) previously equilibrated with the same buffer. Chromatographic separation of yV and 72 globulins was carried out by stepwise elution using two phosphate buffers of different concentrations (Reisfeld and Hyslop, 1966) . Fahey, Wunderlich and Mishell (1964) have described these two forms of 7S immunoglobulin in the mouse, and distinguished them from two further immunoglobulins, namely YlA and iMl; the latter are analogous to the YA and yM (IgA and IgM) of human serum.
72 globulin was eluted with the starting buffer and another eluant (0.282 M K2HPO4, 0*018 M KH2PO4, pH 7.9) was then applied to elute y7 globulins. The protein content in 3 ml. fractions of the eluate was estimated by measuring the extinction at 280 m/t. Fractions comprising the first and second peaks were concentrated separately by ultrafiltration, dialysed against Dulbecco phosphate buffer, and stored at -20°C. until required.
Immunoelectrophoresis was performed by the method of Scheidegger (1955) , using Veronal buffer at pH 8*6 to characterize the differences in electrophoretic mobility of the yV and 72 globulin fractions.
RESULTS

Resistance to challenge
The resistance of immunized mice to challenge with intraperitoneally injected living E.A.T. cells at varying intervals after the third immunizing dose is summarized in Table I .
It was found that a small proportion of the CBA mice immunized with iodoacetate-treated cells resisted challenge with 2-5 x 106 virulent cells administered between 7 and 17 days after the course ofimmunization. However, all the immunized white mice tested under identical conditions developed ascites tumours and died within 15 days after the challenging dose of virulent cells. All the normal mice injected with living E.A.T. cells developed ascites and died within 15 days except one CBA in Batch I. It was later observed that in this animal small solid Delayed Hypersensitivity Mice injected intraperitoneally with E.A.T. preparations according to various schedules were tested for hypersensitivity to the tumour, and some of the results are shown in Table II . A single injection of iodoacetate-treated cells was not sufficient to induce hypersensitivity; however, two or more injections induced a hypersensitivity which was evident at 24 and 48 hours (but not at 6 hours) after the eliciting dose of sonicated cells, that is, a delayed-type hypersensitivity. Most of the measurements were made with an interval of 7-11 days between the last immunizing dose and the eliciting dose, but hypersensitivity was still found in a group of mice tested 27 days after immunization. Although the recorded differences in foot thickness for the hypersensitive mice were not very great, they were observed regularly in many different experiments, and were statistically highly significant (P < 0.001). The reactions of normal non-immunized mice were not significant (P = 0.1-1.0).
There was no hypersensitivity to cell-free ascitic fluid or to iodoacetate-treated E.A.T. cells, when these were used for the eliciting injections. Sonicated E.A.T. cells were not efficient as immunizing injections in the induction of hypersensitivity.
Both strains of mice responded equally well to the immunizing injections, as shown by the development of delayed hypersensitivity.
There was no correlation between the degree of reaction in the hypersensitivity test and the ability of the mice to survive challenge; those mice which survived were not necessarily those which had developed greatest hypersensitivity. (Apffel et al., 1966) , except for using different strains of mice and E.A.T. of different recent history.
No evidence was found for the presence of anti-tumour antibodies in the whole serum, as might have been expected in the face of the poor response to challenge. Nevertheless we fractionated pooled serum from immunized mice and separated 7S y, and 7S Y2 globulins, hoping to find antibody activity in the fractions. In both mice and guinea-pigs, antibodies of these types have been separated and found to have different serological properties (Bloch, 1965 (Hauschka, 1952; Prehn and Main, 1957; Lindenmann, 1964) (Brent, Brown and Medawar, 1958) and raises the possibility that the antigens involved may be histocompatability antigens. Irrespective of the tumour-specific or isoantigenic nature of the iodoacetate-treated E.A.T. cells, they are capable of stimulating an immune reaction. In A-jax mice the reaction is apparently powerful enough to result in the rejection of large doses of living tumour and thus in immunity to challenge; in the mice used in this study (CBA and Herston white), only a moderate-but highly significant-degree of hypersensitivity resulted, and immunity was minimal. The Herston white strain was completely unprotected by the immunizing procedure, although hypersensitivity was readily demonstrated.
It is concluded that the iodoacetate method described is not suitable in all strains of mice for immunization against challenge with E.A.T. If we can assume that the tumours used by Apffel et al. (1966) and ourselves are antigenically similar, then the different mouse strains have behaved differently towards immunization. On the one hand, A-jax mice developed resistance to challenge (other immune reactions were not reported); on the other hand, significant resistance to challenge was not achieved in CBA or Herston white mice, although delayed-type hyper-sensitivity appeared. The existing data do not permit further speculation as to the nature of the immune responses or of the antigens concerned. SUMMARY 1. Mice of two different strains (CBA and Herston white) failed to develop marked resistance to Ehrlich ascites tumour when immunized with iodoacetatetreated tumour cells, a procedure reported by others to be effective in protecting A-jax mice.
2. No circulating anti-tumour antibodies could be detected in the sera of the immunized mice, by a variety of techniques.
3. Delayed-type hypersensitivity to disrupted tumour cells was present in the immunized mice to a highly significant degree; however, this was not correlated with resistance to challenge with live tumour.
4. The possible reasons for the above observations are discussed.
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